Etanercept in therapy multiresistant overlapping Pityriasis lichenoides.

Journal of Drugs in DermatologyVol. 7 Nbr. 10, October 2008

Linked as:

Summary


CASE REPORTS

See the full content of this document

Extract


Etanercept in therapy multiresistant overlapping Pityriasis lichenoides.

ABSTRACT

Introduction: Pityriasis lichenoides (PL) exhibits a protean clinical presentation, particularly in its overlapping form (OPL) combining aspects of the acute and chronic types. Some patients are drug multiresistant and pose a therapeutic dilemma. The anti-tumor necrosis factor (TNF)-a agent etanercept, was recently introduced as an alternative treatment for psoriasis, rheumatoid arthritis, and psoriatic arthritis.

Case Report: A 65-year-old woman ...

See the full content of this document


ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2013, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company